Dr Andria Merrison is the Director of the Bristol MND Centre. The Bristol MND Centre was established, in collaboration with the Motor Neurone Disease Association, in 2010 and provides services for people living with Motor Neurone Disease in the North half of the South West. The centre has particularly developed multi-disciplinary integrated home ventilation services and psychological support for those it serves.
Dr Andria Merrison is also the Director of the South West Neuromuscular Operational Delivery Network (SWNMODN), providing services for people living with other Neuromuscular conditions throughout the South West. This network is the first Neuromuscular ODN in the UK and in 2016 was awarded national Network of Excellence status by Muscular Dystrophy UK.
Dr Andria Merrison trained in Cambridge and Bristol before undertaking Specialist training in Neurology and Intensive Care Medicine in the South West. She went on to further sub-specialist training in Oxford and London. She was awarded an MD for her research into the potential of human bone marrow stem cells for muscle repair.
Davidson A, Siddique F, Lopez M, Lunt P, Carlson H, Moore B, Love S, Roper H, Majumdar A, von der Hagen, M, Huebner A, Jardine P, Merrison A, Curtis E, Jungbluth H, Cullip T, Winder T, Abdelsalam H, Li J, Moore S & Dowling J. (2013) TPM2p.K7del expands the clinical, histopathological and genetic spectrum of TPM2 myopathies. Brain 136:508-21.
Merrison, AFA, Gordon, D & Scolding, NJ (2012) Human adult bone marrow-derived mesenchymal stem cells: factors influencing skeletal muscle differentiation. Journal of Cell Science & Therapy 84, 1-7.
Gordon D, Glover CP, Merrison AF, Uney JB and Scolding NJ. (2008). Enhanced
green fluorescent protein-expressing human mesenchymal stem cells express
neural markers. Journal of Neuroimmunology 193, 59-67.
Merrison AFA & Carpenter RHS (1994). Co-variability of smooth and saccadic latencies in oculomotor pursuit. Ophthalmic Research 26, 158-162.
Merrison AFA & Carpenter RHS (1995). “Express” smooth pursuit. Vision Research 35, 1459-1462
Merrison AFA & Hanna MG (2009) Muscle disease: the bare essentials. Practical Neurology 9(1), 54-65.
Merrison AFA & Fuller GN (2004) Treatment of trigeminal neuralgia. British Medical Journal 237, 1360.
Merrison AFA & Scolding NJ (2003) Acute management of multiple sclerosis. CPD Acute Medicine 2(2).
Merrison AFA & Lhatoo SD (2004) Horner’s syndrome postpartum. British Journal of Obstetrics & Gynaecology 111, 86-88.
Merrison AFA, Dougan CF & Lhatoo SD (2003) Neurological perils of power kites. CPD Acute Medicine 2(3), 98-99.
Merrison AFA, Chidley KE, Dunnett J & Sieradzan, KAS (2002). Wound botulism associated with subcutaneous drug use. Lesson of the week. British Medical Journal 325, 1020-1021.
Merrison AFA, Moss TH, Feller R & Scolding NJ (2002). Cognitive decline, behavioural disturbance and motor dysfunction in a young adult. Practical Neurology 3(1), 36-39.
Merrison AFA & Scolding NJ (2006) Human bone marrow-derived stem cells: myogenic potential and the factors influencing skeletal muscle differentiation. Journal of Neurology, Neurosurgery & Psychiatry. Abstract.
Merrison AFA, Renowden SA, TT Lewis & IEC Ormerod (2003) Cerebral venous sinus thrombosis: treatment with endovascular thrombolysis. Journal of Neurology, Neurosurgery and Psychiatry. Abstract.